Abcuro
MA - Newton
BiotechnologyFocus: T Cell Therapy, Antibodies
Abcuro is a life sciences company focused on T Cell Therapy, Antibodies.
Gene TherapyCell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
ABC008
Inclusion Body MyositisClinical Trials (1)
NCT04659031A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)
Phase 1Phase 1/2
Clinical Trials (1)
NCT05532722ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Phase 1/2Ulviprubart
Inclusion Body Myositis (IBM)Clinical Trials (1)
NCT06450886Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis
Phase 2/3ABC008
Inclusion Body MyositisClinical Trials (1)
NCT05721573A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2004
Portfolio: 4 clinical trials